These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21919379)

  • 1. Torsade de pointes during sevoflurane anesthesia and fluconazole infusion in a patient with long QT syndrome. A case report.
    Tacken MC; Bracke FA; Van Zundert AA
    Acta Anaesthesiol Belg; 2011; 62(2):105-8. PubMed ID: 21919379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torsade de pointes during sevoflurane anesthesia in a child with congenital long QT syndrome.
    Saussine M; Massad I; Raczka F; Davy JM; Frapier JM
    Paediatr Anaesth; 2006 Jan; 16(1):63-5. PubMed ID: 16409532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sevoflurane-associated torsade de pointes in a patient with congenital long QT syndrome genotype 2.
    Kumakura M; Hara K; Sata T
    J Clin Anesth; 2016 Sep; 33():81-5. PubMed ID: 27555138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long QTc interval and torsade de pointes caused by fluconazole.
    Pham CP; de Feiter PW; van der Kuy PH; van Mook WN
    Ann Pharmacother; 2006; 40(7-8):1456-61. PubMed ID: 16849620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SEVOFLURANE AS A CAUSE OF TORSADE DE POINTES IN PATIENT WITH THE LONG QT SYNDROME: Case Report.
    Choromanski DW; Amin S; Zestos MM
    Middle East J Anaesthesiol; 2016 Feb; 23(4):471-4. PubMed ID: 27382818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sevoflurane versus propofol on QT interval.
    Paventi S; Santevecchi A; Ranieri R
    Minerva Anestesiol; 2001 Sep; 67(9):637-40. PubMed ID: 11731753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long QT and torsade de pointes in a patient with acquired human immunodeficiency virus infection in multitherapy with drugs affecting cytochrome P450].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Cassin M; Meneguzzo N; Viel E; Lestuzzi C; Di Gennaro G; Nicolosi GL
    Ital Heart J Suppl; 2004 Sep; 5(9):735-40. PubMed ID: 15568612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].
    Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G
    Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QT interval prolongation, torsade de pointes and renal disease.
    Patanè S; Marte F; Di Bella G; Currò A; Coglitore S
    Int J Cardiol; 2008 Nov; 130(2):e71-3. PubMed ID: 18255176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine.
    Luzza F; Raffa S; Saporito F; Oreto G
    Int J Clin Pract; 2006 May; 60(5):606-8. PubMed ID: 16700864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Torsades de pointes upon fluconazole administration in a patient with acute myeloblastic leukemia.
    Tatetsu H; Asou N; Nakamura M; Hanaoka N; Matsuno F; Horikawa K; Mitsuya H
    Am J Hematol; 2006 May; 81(5):366-9. PubMed ID: 16628725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citalopram induced torsade de pointes, a rare life threatening side effect.
    Kanjanauthai S; Kanluen T; Chareonthaitawee P
    Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias.
    Topilski I; Rogowski O; Rosso R; Justo D; Copperman Y; Glikson M; Belhassen B; Hochenberg M; Viskin S
    J Am Coll Cardiol; 2007 Jan; 49(3):320-8. PubMed ID: 17239713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the effect of sevoflurane on corrected QT prolongation: a pharmacodynamic analysis.
    Han DW; Park K; Jang SB; Kern SE
    Anesthesiology; 2010 Oct; 113(4):806-11. PubMed ID: 20808206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
    Kirchhof P; Franz MR; Bardai A; Wilde AM
    J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
    Elbey MA; Cil H; Onturk E; Islamoglu Y
    Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sevoflurane causes greater QTc interval prolongation in elderly patients than in younger patients.
    Nakao S; Hatano K; Sumi C; Masuzawa M; Sakamoto S; Ikeda S; Shingu K
    Anesth Analg; 2010 Mar; 110(3):775-9. PubMed ID: 20185656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].
    Song L; Yang YM; Zhu J
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Apr; 39(4):293-6. PubMed ID: 21624301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long QT syndrome and torsade de pointes in a patient receiving fluconazole.
    Wassmann S; Nickenig G; Böhm M
    Ann Intern Med; 1999 Nov; 131(10):797. PubMed ID: 10577320
    [No Abstract]   [Full Text] [Related]  

  • 20. A case series of drug-induced long QT syndrome and Torsade de Pointes.
    Tong KL; Lau YS; Teo WS
    Singapore Med J; 2001 Dec; 42(12):566-70. PubMed ID: 11989578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.